why choose us

300×250 Ad Slot

Research Article: Risk of Thrombosis Following the First Dose of ChAdOx nCoV- Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study

Date Published: 2023-09-05

Abstract:
Due to their advanced age and multiple medical comorbidities, patients with end-stage renal disease (ESRD) are at a higher risk of death when they contract coronavirus disease (COVID-). The prevalence of ESRD necessitating dialysis in Taiwan is the highest of any country in the world. While hemodialysis is the predominant modality for renal replacement therapy, patients receiving periodic in-hospital hemodialysis are particularly susceptible to infection with severe acute respiratory syndrome coronavirus- (SARS-CoV-). Therefore, ESRD patients were given top priority in Taiwan’s nationwide COVID- vaccination program. As of st July , more than % of Taiwanese patients with ESRD had received their first dose of ChAdOx nCoV- (Oxford-AstraZeneca) vaccine, which was largely the only COVID- vaccine available to the nationwide vaccination program before th June .,

Introduction:
Due to their advanced age and multiple medical comorbidities, patients with end-stage renal disease (ESRD) are at a higher risk of death when they contract coronavirus disease (COVID-). The prevalence of ESRD necessitating dialysis in Taiwan is the highest of any country in the world. While hemodialysis is the predominant modality for renal replacement therapy, patients receiving periodic in-hospital hemodialysis are particularly susceptible to infection with severe acute respiratory syndrome coronavirus-…

Read more

300×250 Ad Slot